Pharmaceutical giant Pfizer has received U.S. approval for a gene therapy against a form of hemophilia, a rare and inherited blood clotting disorder, the company said Friday. Beqvez, which is given as a single intravenous infusion, was shown in a clinical trial of 45 people to be better at (...)
Site référencé: Raw Story
Raw Story
Richard Sherman, songwriter behind Disney hits, dead at 95
26/05/2024
'You keep answering about Joe Biden' : CNN host nails Tim Scott for dodging on Trump
26/05/2024
'That went well' : MSNBC panel laughs at Trump going down in flames in Saturday speech
26/05/2024
Trump posts shocking obscenity-filled attack on Joe Scarborough for Memorial Day
26/05/2024
